Sign In
Buy CDNA
$38.37
-1.36 (-3.42%)
At Close: Jul 20, 2026
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Rating of “Hold” from Brokerages
01:10am, Monday, 22'nd Dec 2025
Shares of CareDx, Inc. (NASDAQ: CDNA - Get Free Report) have been given a consensus recommendation of "Hold" by the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. Fi
CareDx Provides Notice of Proposed Derivative Settlement
05:00pm, Thursday, 18'th Dec 2025
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) today provided notice of proposed settlement of derivative actions and settlement hearing. UNITED STATES DISTRICT COURT NORTHERN DISTRICT
Geode Capital Management LLC Purchases 43,074 Shares of CareDx, Inc. $CDNA
03:59am, Saturday, 29'th Nov 2025
Geode Capital Management LLC boosted its holdings in shares of CareDx, Inc. (NASDAQ: CDNA) by 3.4% during the second quarter, according to the company in its most recent Form 13F filing with the Secur
Wall Street Analysts Believe CareDx (CDNA) Could Rally 28.02%: Here's is How to Trade
10:55am, Thursday, 27'th Nov 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 28% in CareDx (CDNA). While the effectiveness of this highly sought-after metric is questionable, the positive
Envestnet Asset Management Inc. Acquires 3,389 Shares of CareDx, Inc. $CDNA
04:24am, Wednesday, 26'th Nov 2025
Envestnet Asset Management Inc. boosted its holdings in CareDx, Inc. (NASDAQ: CDNA) by 17.7% during the second quarter, according to the company in its most recent filing with the Securities and Excha
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differenti
Aviva PLC Increases Position in CareDx, Inc. $CDNA
04:00am, Friday, 14'th Nov 2025
Aviva PLC increased its stake in shares of CareDx, Inc. (NASDAQ: CDNA) by 19.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commi
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 07'th Nov 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercializ
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
08:00am, Thursday, 06'th Nov 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercializ
Analyzing Progyny (NASDAQ:PGNY) and CareDx (NASDAQ:CDNA)
02:30am, Wednesday, 05'th Nov 2025
Progyny (NASDAQ: PGNY - Get Free Report) and CareDx (NASDAQ: CDNA - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based
CareDx, Inc (CDNA) Q3 2025 Earnings Call Transcript
10:16pm, Tuesday, 04'th Nov 2025
CareDx, Inc ( CDNA ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Tina Jacobsen John Hanna - President, CEO & Director Nathan Smith - Chief Financial Officer Keith Kennedy -
CareDx (CDNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
08:01pm, Tuesday, 04'th Nov 2025
While the top- and bottom-line numbers for CareDx (CDNA) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compar
CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates
07:16pm, Tuesday, 04'th Nov 2025
CareDx (CDNA) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.14 per share a year ago.
CareDx Announces Third Quarter 2025 Financial Results
04:05pm, Tuesday, 04'th Nov 2025
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company — a leading precision medicine company focused on the discovery, development and commercialization of clinic
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
07:05am, Monday, 27'th Oct 2025
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of c
